Laura Ritsema, OT | |
5400 S Pennsylvania Ave, Lansing, MI 48911-4049 | |
(517) 393-7325 | |
Not Available |
Full Name | Laura Ritsema |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 5400 S Pennsylvania Ave, Lansing, Michigan |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1083909287 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 5201005710 (Michigan) | Primary |
Mailing Address | Practice Location Address |
---|---|
Laura Ritsema, OT 5400 S Pennsylvania Ave, Lansing, MI 48911-4049 Ph: () - | Laura Ritsema, OT 5400 S Pennsylvania Ave, Lansing, MI 48911-4049 Ph: (517) 393-7325 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced it has received commitments from certain institutional investors to purchase an aggregate of $10 million of Rexahn's securities in a registered direct offering.
Like a string of pearls, the spine is made of a series of similar vertebrae. A so-called segmentation clock creates this repetitive arrangement in developing embryos: Each time the clock ticks, a vertebra starts to form.
Atonomics announces today that it has entered into an agreement with Omron Healthcare, which will enable Atonomics to advance the development of the AtolyzerConsumer device for advanced diagnostic testing of lifestyle diseases in a consumer pharmacy setting. As part of the transaction Omron Healthcare is taking a minority equity stake in Atonomics.
The Squirrel Hill Health Center in Pittsburgh is one of many community health centers that will see a significant funding increase under the health overhaul law, according to the Pittsburgh Post-Gazette.
Abbott (NYSE: ABT) announced today that the Chinese State Food and Drug Administration (SFDA) has approved its XIENCE V(R) Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease (CAD) - the leading cause of death in China. XIENCE V is the only drug eluting stent to have demonstrated superiority over the TAXUS(R) Paclitaxel-Eluting Coronary Stent System (TAXUS) in the primary endpoints of two randomized, pivotal (phase III) clinical trials.
› Verified 5 days ago
Alicia Blondell, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2100 E Provincial House Dr, Lansing, MI 48910 Phone: 517-272-4029 | |
Elizabeth Corder, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4323 W Willow Hwy, Lansing, MI 48917 Phone: 810-869-2369 | |
Kirsten Paige Schneider, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1215 E Michigan Ave, Lansing, MI 48912 Phone: 517-253-2577 | |
Jobi Mccarthy, OTD, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 836 Centennial Way Ste 160, Lansing, MI 48917 Phone: 517-798-3677 | |
Anne Shivley, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3315 E Michigan Ave Ste 4, Lansing, MI 48912 Phone: 517-364-8600 | |
Cynthia Grider, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 812 E Jolly Rd, Ste 216, Lansing, MI 48910 Phone: 517-346-9531 Fax: 517-346-8291 | |
Gail Ann Shafer, PHD, OTR, CHT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 4052 Legacy Pkwy Ste 100, Lansing, MI 48911 Phone: 517-394-0775 |